DOI: 10.1055/s-00033990

TH Open

Issue 03 · Volume 03 · July 2019 DOI: 10.1055/s-009-43579

Original Article

e203
e216
Kicken, Cécile H.; van der Vorm, Lisa N.; Zwaveling, Suzanne; Schoenmaker, Evi; Remijn, Jasper A.; Huskens, Dana; de Laat, Bas: A Hypoxic Environment Attenuates Exercise-Induced Procoagulant Changes Due to Decreased Platelet Activation
e230
Albiñana, Virginia; Giménez-Gallego, Guillermo; García-Mato, Angela; Palacios, Patricia; Recio-Poveda, Lucia; Cuesta, Angel-M; Patier, José-Luis; Botella, Luisa-María: Topically Applied Etamsylate: A New Orphan Drug for HHT-Derived Epistaxis (Antiangiogenesis through FGF Pathway Inhibition)
e244
Stainer, Alexander R.; Sasikumar, Parvathy; Bye, Alexander P.; Unsworth, Amanda J.; Holbrook, Lisa M.; Tindall, Marcus; Lovegrove, Julie A.; Gibbins, Jonathan M.: The Metabolites of the Dietary Flavonoid Quercetin Possess Potent Antithrombotic Activity, and Interact with Aspirin to Enhance Antiplatelet Effects

Letter to the Editor

e227
Li, Bojun; Heldner, Mirjam R.; Arnold, Marcel; Coutinho, Jonathan M.; Zuurbier, Susanna M.; Meijers, Joost C. M.; Kohler, Hans P.; Schroeder, Verena: Coagulation Factor XIII in Cerebral Venous Thrombosis
e259
Olie, Renske H.; van der Meijden, Paola E. J.; Spronk, Henri M. H.; van Oerle, Rene; Barvik, Stale; Bonarjee, Vernon V. S.; ten Cate, Hugo; Nilsen, Dennis W. T.: Effects of the PAR-1 Antagonist Vorapaxar on Platelet Activation and Coagulation Biomarkers in Patients with Stable Coronary Artery Disease